Ekaterina O. Vorontsova

Ekaterina O. Vorontsova


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
AZA. V. Zinina
A. V. Zinina
Olga ShchaginaOlga Shchagina
Olga Shchagina
Dystrophinopathies are a spectrum of X-linked muscular disorders associated with pathogenic/likely pathogenic variants in the dystrophin gene (DMD). Typically, the condition develops in males, but cases of symptom manifestation have also been described in females. The review presents contemporary data on the manifestations of dystrophinopathies in women with pathogenic variants in the DMD gene, discussing the reasons for the varying degrees of symptom expression in carrier women with pathogenic/ likely pathogenic variants. It discusses the importance of mutation screening in the DMD gene for women presenting with muscular dystrophy symptoms and investigating carrier status in relatives of patients with Duchenne/Becker muscular dystrophy.

Verified
Journal Article
Open access
PDF file
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
AMAysylu Murtazina
Aysylu Murtazina
EKElena Kistol
Elena Kistol
Aleksander V. PolyakovAleksander V. Polyakov
Aleksander V. Polyakov
MSMaria Sumina
Maria Sumina
Olga ShchaginaOlga Shchagina
Olga Shchagina
Duchenne muscular dystrophy (DMD) is typically described in boys with a pathogenic variant in the DMD. However, in certain cases, females may also exhibit symptoms of this X-linked disorder. In the present study, the cause of Duchenne muscular dystrophy in three girls was reciprocal translocations t(X;2), t(X;12), and t(X;16), with breakpoints located within the DMD gene sequence. All patients had global development delay, predominantly proximal muscle weakness, calf muscle hypertrophy, and elevated creatine kinase levels up to 100 times the normal range (16,000–26,694 U/L). All underwent cardiac ultrasound and electromyography, and two of the girls also had muscle MRI data. After receiving negative results of MLPA aimed at the detection of DMD deletions and duplications, as well as the limb-girdle muscular dystrophy gene panel sequencing, the patients were referred to whole genome sequencing, which allowed to detect a translocation involving the short arm of the X chromosome and with breakpoints in the DMD. Karyotyping confirmed reciprocal translocations in all patients, with de novo status established in all three cases. The results of this study contribute to the understanding of clinical polymorphism and genetic heterogeneity of the disease, highlighting the importance of a comprehensive approach to genetic diagnostics in atypical cases.

22 October 2025 in Genes
Verified
Journal Article
Open access
PDF file
Ekaterina NuzhnayaEkaterina Nuzhnaya
Ekaterina Nuzhnaya
MSMargarita Sharova
Margarita Sharova
Uliana V ChubykinaUliana V Chubykina
Uliana V Chubykina
AOAnna Orlova
Anna Orlova
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
PVPetr Vasilev
Petr Vasilev
We describe the first genetically confirmed familial case of nonsyndromic cardiac progeria caused by the LMNA NM_170707.4:c.898G>A (p.Asp300Asn) variant, with evidence suggesting gonadal mosaicism as the mechanism of inheritance. The proband developed severe early-onset valvular and coronary artery disease requiring multiple surgical interventions, yet showed no systemic progeroid features. Genetic analysis revealed the heterozygous variant in her unaffected daughters and nieces but not in either parent. Comparison with previously reported cases highlights striking clinical heterogeneity associated with this variant, ranging from isolated cardiovascular involvement to syndromic progeroid manifestations with metabolic and skeletal abnormalities. This variability likely reflects the combined influence of genetic, epigenetic, and environmental factors. Our case expands the clinical spectrum of LMNA p.Asp300Asn and underscores the importance of considering laminopathies in patients with unexplained early-onset cardiac disease. Early genetic diagnosis is essential for the management, surveillance, and counseling of affected families.

1 January 2025 in Онтогенез / Russian Journal of Developmental Biology
Verified
Journal Article
Closed access
PSPolina Sirotkina
Polina Sirotkina
VBV.E. Blohin
V.E. Blohin
PVP.A. Vasil'Ev
P.A. Vasil'Ev
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
AKA.L. Kungurceva
A.L. Kungurceva
VAV.K. Abdyev
V.K. Abdyev
Синдром Коккейна (СК) — аутосомно-рецессивное заболевание, в число проявлений которого входит прогероидный синдром. Его причиной служат мутации в одном из двух генов, продукты которых участвуют в репарации ДНК: и . Нами была поставлена цель репрограммировать CSB/ERCC6 мутантные фибробласты пациента с СК в индуцированные плюрипотентные стволовые клетки (ИПСК). В нашем исследовании дермальные фибробласты с компаундгетерозиготными мутациями с.2566C>T (p.Gln856Ter) и с.1821+1G>A в гене были репрограммированы в линию ИПСК (ИПСКСК1) благодаря применению эписомальных плазмид, несущих последовательности генов , , , , , и . Линия ИПСКСК1 продемонстрировала характеристики плюрипотентности: экспрессию маркеров плюрипотентности и способность дифференцироваться в производные всех трех зародышевых листков. При спонтанной дифференцировке линии ИПСКСК1 выявлено снижение экспрессии нейроэктодермального маркера .

5 February 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
Valeriia KovalskaiaValeriia Kovalskaia
Valeriia Kovalskaia
TCTatiana B. Cherevatova
Tatiana B. Cherevatova
EKElena Kistol
Elena Kistol
OSOlga A. Shagina
Olga A. Shagina
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
OROxana Ryzhkova
Oxana Ryzhkova
Background: Hypohidrotic ectodermal dysplasia (HED) encompasses a group of rare genetic disorders affecting two or more ectodermal derivatives (hair, teeth, nails, certain glands). The condition can be inherited in an X-linked, autosomal dominant, or autosomal recessive manner, with the majority of cases caused by mutations in the EDA , EDAR , EDARADD , and WNT10A genes. This study aimed to evaluate the distribution of pathogenic and likely pathogenic variants in 261 unrelated families affected by HED in the Russian Federation (comprising 455 patients in total) between 2007 and 2024. To achieve this objective, we employed Sanger sequencing, targeted gene panel sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), and segregation analysis to clarify the pathogenicity of variants of uncertain significance. Results: A total of 261 unrelated probands, comprising 196 males (75.1%) and 65 females (24.9%), were included. Pathogenic or likely pathogenic variants were identified in 183 probands (70.1%). The distribution of mutated genes was as follows: EDA ( n = 155, 84.7%), WNT10A ( n = 16, 8.8%), and EDAR ( n = 12, 6.5%). No apparent pathogenic mutations were detected in EDARADD . Additionally, we report 46 novel causative variants for HED, along with recurrent mutations in the EDA , WNT10A , and EDAR genes. We also identified that 28.8% of all causative variants in EDA are de novo . Conclusion: This is the only molecular study conducted in the Russian population affected by HED and represents the largest HED cohort published to date globally. Our findings significantly expand the mutational spectrum of HED-causing genes and will aid in choosing an initial diagnostic approach for HED patients. Further studies using whole-genome sequencing (WGS) will help to identify other contributory genes in the remaining uncharacterized Russian patients with HED.

13 November 2026 in Neuromuscular Diseases
Verified
Journal Article
Open access
EVEkaterina O. Vorontsova
Ekaterina O. Vorontsova
AMAysylu Murtazina
Aysylu Murtazina
Aleksander V. PolyakovAleksander V. Polyakov
Aleksander V. Polyakov
Olga ShchaginaOlga Shchagina
Olga Shchagina
Currently, the validity of classifying X-linked disorders as either dominant or recessive is being increasingly called into question. This pertains in particular to muscular dystrophies caused by pathogenic variants in the DMD, MTM1, FHL1, and EMD genes. Women carrying heterozygous variants in genes associated with X-linked recessive conditions are often regarded as asymptomatic carriers—a perception that stems from underdiagnosis, despite the presence of clinical manifestations. According to survey findings, the majority of female carriers do not receive adequate medical genetic counseling and are not informed about the potential clinical manifestations of the disease. To date, there is no unequivocal explanation for the presence or absence of clinical symptoms in women with heterozygous pathogenic variants in these genes. It is believed that the primary cause of the variability in clinical manifestations among carriers is the differential degree of X-chromosome inactivation across tissues; however, this process is also governed by more complex mechanisms. The prognosis of disease progression, the social implications, and the precise scope of medical and social care required by affected patients remain insufficiently studied. The aim of this review is to raise physician awareness regarding issues pertaining to the manifestations of X-linked disorders in female carriers. Particular attention is paid to carriers of heterozygous variants in the DMD, MTM1, FHL1, and EMD genes, which are responsible for X-linked muscular dystrophies.